Q1 FY2027 · ended Jun 30, 2026 · Revenue $337,572, +13.5% YoY · Filed Aug 14, 2026
PetVivo Holdings, Inc. (PETV) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q1 of fiscal 2027, the quarter ended Jun 30, 2026, it reported revenue of $337,572 and a net loss of $1.6 million. Free cash flow was -$978,149. As of Jun 30, 2026 it held $122,633 in cash and investments and $38,654 in total debt.
Revenue
$337,572
+13.5% vs year-ago quarter
Net income
$-1.61M
+30.2% vs year-ago quarter
Operating cash flow
$-965,779
+40.9% vs year-ago quarter
Free cash flow
$-978,149
-20.4% vs prior quarter
EPS
$-0.05
+50.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
37.95M
+36.0% vs year-ago quarter
Net cash
$83,979
Q1 FY2027
Operating margin
-747.0%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PETV (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Edina, MN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1512922
- Former names
- Technologies Scan Corp (until May 2, 2014)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Jun 30, 2026 |
Q4 FY2026 Mar 31, 2026 |
Q3 FY2026 Dec 31, 2025 |
Q2 FY2026 Sep 30, 2025 |
Q1 FY2026 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $337,572 | $254,715 | $286,108 | $303,284 | $297,500 |
| Operating income | -$1.6M | -$3.0M | -$2.2M | -$2.1M | -$1.8M |
| Net income | -$1.6M | -$3.0M | -$2.2M | -$3.0M | -$2.3M |
| Diluted EPS | -$0.05 | -$0.08 | -$0.07 | -$0.11 | -$0.10 |
| Operating cash flow | -$965,779 | -$812,382 | -$1.5M | -$2.2M | -$1.6M |
| Free cash flow | -$978,149 | -$812,382 | -$1.5M | -$2.2M | — |
| Total assets | $2.7M | $3.6M | $4.4M | $5.3M | $6.9M |
| Total liabilities | $1.3M | $1.4M | $997,404 | $1.1M | $3.2M |
| Stockholders' equity | $1.4M | $2.2M | $3.4M | $4.2M | $3.0M |
| Cash and investments | $122,633 | $350,782 | $18,164 | $767,914 | $3.3M |
| Total debt | $38,654 | $54,711 | $70,560 | $86,318 | $890,979 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Jul 29, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 27, 2026 | Jul 23, 2026 |
All 697 PetVivo Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.